Publications by authors named "Laure S Fournier"

Article Synopsis
  • * Methods: Researchers used the EURAD database to analyze cases from March 2018, categorizing patients based on the O-RADS MRI score to determine the necessity of surgery or follow-up.
  • * Results: The O-RADS MRI score showed high accuracy (97.2%) in identifying masses, potentially reducing unnecessary surgeries for benign cases while only missing a few malignant cases, indicating improved management strategies.
View Article and Find Full Text PDF

Purpose: To propose a new quality scoring tool, METhodological RadiomICs Score (METRICS), to assess and improve research quality of radiomics studies.

Methods: We conducted an online modified Delphi study with a group of international experts. It was performed in three consecutive stages: Stage#1, item preparation; Stage#2, panel discussion among EuSoMII Auditing Group members to identify the items to be voted; and Stage#3, four rounds of the modified Delphi exercise by panelists to determine the items eligible for the METRICS and their weights.

View Article and Find Full Text PDF

Metastatic tumor deposits in bone marrow elicit differential bone responses that vary with the type of malignancy. This results in either sclerotic, lytic, or mixed bone lesions, which can change in morphology due to treatment effects and/or secondary bone remodeling. Hence, morphological imaging is regarded unsuitable for response assessment of bone metastases and in the current Response Evaluation Criteria In Solid Tumors 1.

View Article and Find Full Text PDF

Background Improving the differentiation of uterine sarcomas from atypical leiomyomas remains a clinical challenge and is needed to avoid inappropriate surgery. Purpose To develop a diagnostic algorithm including diffusion-weighted MRI criteria to differentiate malignant uterine sarcomas from benign atypical leiomyomas. Materials and Methods This case-control retrospective study identified women with an atypical uterine mass at MRI between January 2000 and April 2017, with surgery or MRI follow-up after 1 year or longer.

View Article and Find Full Text PDF

Objectives: Multidisciplinary tumour boards (MTBs) play an increasingly important role in managing cancer patients from diagnosis to treatment. However, many problems arise around the organisation of MTBs, both in terms of organisation-administration and time management. In this context, the European Society of Oncologic Imaging (ESOI) conducted a survey among its members, aimed at assessing the quality and amount of involvement of radiologists in MTBs, their role in it and related issues.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how different levels of manual pressure affect the accuracy of Shear Wave Elastography (SWE) in diagnosing breast lesions and to check the reliability between different radiologists.
  • The research involved 60 breast masses (26 benign and 34 malignant) examined by a specialized radiologist, comparing stiffness measurements at four pressure levels: none, mild, moderate, and marked.
  • Results showed that compression significantly improved the accuracy of SWE in differentiating between benign and malignant lesions, supporting the recommendation to incorporate compression in routine clinical evaluations.
View Article and Find Full Text PDF

Importance: Approximately one-quarter of adnexal masses detected at ultrasonography are indeterminate for benignity or malignancy, posing a substantial clinical dilemma.

Objective: To validate the accuracy of a 5-point Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score for risk stratification of adnexal masses.

Design, Setting, And Participants: This multicenter cohort study was conducted between March 1, 2013, and March 31, 2016.

View Article and Find Full Text PDF

Our objective was to determine if supersonic shear wave elastography (SSWE) can detect changes in stiffness of a breast cancer model under therapy. A human invasive carcinoma was implanted in 22 mice. Eleven were treated with an anti-angiogenic therapy and 11 with glucose for 24 d.

View Article and Find Full Text PDF
Article Synopsis
  • Doctors have found new drugs that help treat a type of kidney cancer called metastatic renal cell carcinoma (mRCC), which targets specific proteins in the body.
  • With these new treatments, patients can now live about 2 years longer than before they started using these medications.
  • Scientists are now trying to figure out what signs they can look for to predict how well patients will respond to these new drugs and improve treatment options even further.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied if using special imaging techniques could help watch how well certain cells (called mural progenitor cells) were working in treating tumors in mice.
  • They found that mice treated with these cells had less tumor growth compared to other mice and showed other signs that the treatment was helping.
  • Overall, the research suggests that these cells can slow down tumor growth and make it easier for the body to handle the tumors better.
View Article and Find Full Text PDF

Fibered confocal fluorescence in vivo imaging with a fiber optic bundle uses the same principle as fluorescent confocal microscopy. It can excite fluorescent in situ elements through the optical fibers, and then record some of the emitted photons, via the same optical fibers. The light source is a laser that sends the exciting light through an element within the fiber bundle and as it scans over the sample, recreates an image pixel by pixel.

View Article and Find Full Text PDF

Purpose: To determine whether diffusion-weighted imaging (DWI) characteristics could predict the effectiveness of uterine arterial embolization in treatment of fibroids.

Methods: This retrospective study included 17 women (27 fibroids) who underwent uterine arterial embolization for fibroids. MR imaging (1.

View Article and Find Full Text PDF

Kidney cancer is composed of several bio-histological entities. The most frequent type, clear-cell carcinoma, is not homogenous regarding gene mutations or transcriptomic profiles, but the biologic classifications are not yet mature. Therefore, biologically driven strategies of treatment have not yet been developed in the clinical setting.

View Article and Find Full Text PDF

Background And Objectives: Objective response as determined by Response Evaluation Criteria in Solid Tumors (RECIST) is low among patients with metastatic renal cell carcinoma (mRCC) treated with targeted agents, despite significantly improved progression-free survival (PFS). A modified response threshold may be more clinically meaningful than RECIST for identifying patients who may derive a PFS benefit from targeted therapy.

Patients And Methods: We performed a retrospective analysis of data from the phase III RECORD-1 trial of everolimus versus placebo in patients with mRCC who had failed sunitinib or sorafenib (ClinicalTrials.

View Article and Find Full Text PDF

Purpose: To develop a new automated filtering technique and to evaluate its ability to compensate for the known low contrast-to-noise ratio (CNR) in dynamic contrast material-enhanced (DCE) magnetic resonance (MR) and computed tomographic (CT) data, without substantial loss of information.

Materials And Methods: Clinical data acquisition for this study was approved by the institutional review board. Principal component analysis (PCA) was combined with the fraction of residual information (FRI) criterion to optimize the balance between noise reduction efficiency and information conservation.

View Article and Find Full Text PDF

Purpose: To determine whether tumor perfusion parameters assessed by using dynamic contrast material-enhanced computed tomography (CT) could help predict and detect response in patients receiving antiangiogenic therapy for metastatic renal cell carcinoma.

Materials And Methods: Institutional ethics committee approval and informed consent were obtained. In two phase-III trials involving 51 patients with metastatic renal cell carcinoma (38 men, 13 women; age range, 30-80 years) receiving antiangiogenic drugs (sorafenib [n = 10], sunitinib [n = 22]), a placebo (n = 12), or interferon alfa (n = 7), serial dynamic contrast-enhanced CT was performed, during 90 seconds before and after injection of 80 mL of iobitridol.

View Article and Find Full Text PDF

Purpose: To prospectively determine the diagnostic accuracy of optical absorption imaging in patients with Breast Imaging Reporting and Data System (BI-RADS) 3-5 breast lesions.

Materials And Methods: Forty-six patients with BI-RADS classification 3 (11%), 4 (44%) or 5 (44%) lesions, underwent a novel optical imaging examination using red light to illuminate the breast. Pressure was applied on the breast, and time-dependent curves of light absorption were recorded.

View Article and Find Full Text PDF

The authors present a case of unusually aggressive adenoid cystic carcinoma of the head and neck. The patient presented with sciatica one year after initial diagnosis. She was otherwise asymptomatic.

View Article and Find Full Text PDF

Diagnostic contrast media for magnetic resonance imaging (MRI) are often applied to enhance the signal of blood allowing for quantitative definition of vascular functional characteristics including tissue blood volume, flow, and leakiness. Well-tolerated and safe macromolecular formulations are currently being sought that remain in the blood for a relatively long period and that leak selectively from diseased vessels, particularly cancer vessels. We synthesized a new class of macromolecular, water-soluble MRI contrast media by introducing two diverging polylysine cascade amplifiers at each end of a poly(ethylene glycol) (PEG) backbone, followed by substitution of terminal lysine amino groups with Gd-DTPA chelates.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to see if a special imaging technique could show how blood vessels change when a cancer drug is used on breast cancer in rats.
  • Researchers gave one group of rats a drug called celecoxib and another group a salt water solution for comparison.
  • The results showed that the drug group had less blood flow in their tumors after 7 days, which suggests the drug helped slow down the growth of blood vessels in the cancer.
View Article and Find Full Text PDF